Tandem Diabetes Care has received the Food and Drug Administration’s green light for the Tandem Mobi insulin pump for people with diabetes aged 6 years old and older. The Tandem Mobi is fully ...

Tandem Diabetes Care's t:slim X2 Insulin Pump Automated Insulin Delivery System is now the first to incorporate the Abbott FreeStyle Libre 2 Plus Sensor for users in the United States. The FreeStyle ...

SAN DIEGO, September 29, 2025--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that its t:slim X2™ insulin pump ...

Abbott Laboratories has taken a big step in diabetes management by integrating its glucose sensor with a Tandem insulin pump, creating a hybrid closed-loop insulin delivery system. The two companies ...

After a successful limited rollout of its newest insulin pump in the U.S., Tandem Diabetes Care is picking up the pace. The Mobi pump will now begin a widespread national launch, with Tandem already ...

CHICAGO (Reuters) - The U.S. Food and Drug Administration on Friday granted approval for Tandem Diabetes Care's software program that uses readings from a continuous glucose monitor to predict and ...

After stumbling a bit in the second quarter of the year, Tandem Diabetes is getting back on its feet, multi-quarter recovery plan already in place. While those three months saw Tandem’s global sales ...

SAN DIEGO--(BUSINESS WIRE)-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company today announced the Tandem t:slim X2™ insulin pump with Control-IQ+ ...

This sub-analysis is the first study to evaluate AID outcomes for people with type 2 diabetes using the Center for Medicare and Medicaid Services (CMS) criteria for insulin pump coverage. Of the 319 ...